JP2009534458A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534458A5
JP2009534458A5 JP2009507166A JP2009507166A JP2009534458A5 JP 2009534458 A5 JP2009534458 A5 JP 2009534458A5 JP 2009507166 A JP2009507166 A JP 2009507166A JP 2009507166 A JP2009507166 A JP 2009507166A JP 2009534458 A5 JP2009534458 A5 JP 2009534458A5
Authority
JP
Japan
Prior art keywords
independently
ring
alkyl
substituent
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009507166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534458A (ja
Filing date
Publication date
Priority claimed from GB0608269A external-priority patent/GB0608269D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/001537 external-priority patent/WO2007125331A2/en
Publication of JP2009534458A publication Critical patent/JP2009534458A/ja
Publication of JP2009534458A5 publication Critical patent/JP2009534458A5/ja
Withdrawn legal-status Critical Current

Links

JP2009507166A 2006-04-26 2007-04-26 アミノ−エチル−アミノ−アリール(aeaa)化合物およびそれらの使用 Withdrawn JP2009534458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74563006P 2006-04-26 2006-04-26
GB0608269A GB0608269D0 (en) 2006-04-26 2006-04-26 Therapeutic compounds
PCT/GB2007/001537 WO2007125331A2 (en) 2006-04-26 2007-04-26 Amino-ethyl-amino-aryl (aeaa) compounds and their use

Publications (2)

Publication Number Publication Date
JP2009534458A JP2009534458A (ja) 2009-09-24
JP2009534458A5 true JP2009534458A5 (cg-RX-API-DMAC10.html) 2010-06-17

Family

ID=38581449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507166A Withdrawn JP2009534458A (ja) 2006-04-26 2007-04-26 アミノ−エチル−アミノ−アリール(aeaa)化合物およびそれらの使用

Country Status (8)

Country Link
US (1) US20090247519A1 (cg-RX-API-DMAC10.html)
EP (1) EP2024333A2 (cg-RX-API-DMAC10.html)
JP (1) JP2009534458A (cg-RX-API-DMAC10.html)
AU (1) AU2007245496A1 (cg-RX-API-DMAC10.html)
CA (1) CA2649995A1 (cg-RX-API-DMAC10.html)
IL (1) IL194899A0 (cg-RX-API-DMAC10.html)
MX (1) MX2008013718A (cg-RX-API-DMAC10.html)
WO (1) WO2007125331A2 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069976A2 (en) * 2006-12-01 2008-06-12 President And Fellows Of Harvard College Compounds and methods for enzyme-mediated tumor imaging and therapy
KR20090129488A (ko) 2007-03-22 2009-12-16 버텍스 파마슈티칼스 인코포레이티드 야누스 키나아제의 억제제로서 유용한 n-헤테로사이클릭 화합물
KR20110040818A (ko) 2008-06-10 2011-04-20 노파르티스 아게 상피 나트륨 채널 차단제로서의 피라진 유도체
BRPI0915105A2 (pt) * 2008-06-13 2019-09-24 Novartis Ag composto de 2,4'-biripidinila como inibidores da proteína cinase d úteis para o tratamento de ia insuficiência cardíaca e cancer
EP2440533B1 (en) 2009-06-12 2015-09-23 Socpra-Sciences Et Génie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
EP2480537A1 (en) * 2009-09-24 2012-08-01 Basf Se Aminoquinazoline compounds for combating invertebrate pests
EP2528606B1 (en) * 2010-01-28 2014-09-24 Alexander Levitzki Quinazoline-based t cell proliferation inhibitors
EP2550361B1 (en) 2010-03-25 2017-02-08 The J. David Gladstone Institutes Compositions and methods for treating neurological disorders
CA3056970A1 (en) 2017-03-21 2018-09-27 Bayer Pharma Aktiengesellschaft 2-methyl-quinazolines
EP3781565A1 (en) 2018-04-18 2021-02-24 Bayer Pharma Aktiengesellschaft 2-methyl-aza-quinazolines
EP3787612A4 (en) 2018-05-04 2021-11-17 Remedy Plan, Inc. CANCER TREATMENTS AGAINST CANCER STEM CELLS
JP2022544700A (ja) * 2019-08-22 2022-10-20 バイオヘイブン・セラピューティクス・リミテッド 筋萎縮性側索硬化症および関連障害の治療のためにtdp-43に結合する分子
PH12022551081A1 (en) 2019-11-06 2024-06-19 Remedy Plan Inc Cancer treatments targeting cancer stem cells
EP4192826A4 (en) * 2020-08-07 2024-09-04 Athos Therapeutics, Inc. SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER
WO2022185253A1 (en) 2021-03-03 2022-09-09 Instytut Biologii doswiadczalnej imienia Marcelego Nenckiego Polskiej Akademii Nauk Inhibitor of protein kinase d for use in prevention or treatment of hyperlipidemia
EP4052700A1 (en) * 2021-03-03 2022-09-07 Instytut Biologii doswiadczalnej imienia Marcelego Nenckiego Polskiej Akademii Nauk Inhibitor of protein kinase d (pkd) for use in prevention or treatment of obesity and a pharmaceutical composition for such use
CN117062599A (zh) * 2021-03-03 2023-11-14 波兰国家科学院专业生物学研究所 用于预防或治疗高脂血症的蛋白激酶d抑制剂
CN117924190B (zh) * 2024-01-19 2026-07-17 重庆医科大学 2-苯基-4-胺基喹唑啉类化合物或其可药用盐及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2412345A1 (en) * 1999-06-16 2000-12-21 University Of Iowa Research Foundation Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
JP4272338B2 (ja) * 2000-09-22 2009-06-03 バイエル アクチェンゲゼルシャフト ピリジン誘導体
ATE466581T1 (de) * 2001-12-07 2010-05-15 Vertex Pharma Verbindungen auf pyrimidin-basis als gsk-3-hemmer
AU2003255482A1 (en) * 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
CA2531061A1 (en) * 2003-07-02 2005-01-13 Vertex Pharmaceuticals Incorporated Pyrimidines useful as modulators of voltage-gated ion channels
CR9465A (es) * 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente

Similar Documents

Publication Publication Date Title
CN105906617B (zh) Hec1活性调节剂及其方法
JP6031122B2 (ja) 抗微生物療法のための三環式ホウ素化合物
CN109071498A (zh) 激酶抑制剂及其制备方法和用途
EP3162801B1 (en) Salt of halogen-substituted heterocyclic compound
JP2014501766A5 (cg-RX-API-DMAC10.html)
JP7446460B2 (ja) 新規ep4拮抗薬の合成及びその癌及び炎症における使用
CZ243093A3 (en) Benzofuran derivatives, process of their preparation and pharmaceutical preparations in which they are comprised
An et al. The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer
JP2020506970A5 (cg-RX-API-DMAC10.html)
KR20130121857A (ko) 다발성 골수종의 치료 효과를 갖는 피라졸 화합물
US20160289204A1 (en) Griseofulvin derivatives
CN106749097B (zh) 一种6-氯-2-氨基苯并噻唑类衍生物及其制备方法和应用
US11787790B2 (en) Benzimidazole derivative having fluorine-containing substituent, preparation and application thereof
US20250144250A1 (en) Ph-sensitive fluorophores
RU2510394C1 (ru) Производное селеназола, имеющее лиганд, который активирует рецептор, активируемый пролифератором пероксисом ( ppar ), способ его получения и применение химических соединений
WO2023134751A1 (zh) 微管蛋白-Src双靶点抑制剂和用途
JP2024517443A5 (cg-RX-API-DMAC10.html)
US20170029404A1 (en) Polysubstituted pyridine compound, preparation method, use and pharmaceutical composition
WO2019105234A1 (zh) 芳香族化合物及其药物组合物和用途
JP5701387B2 (ja) ベルバミンのジカルボキシミド誘導体、その調製方法及び使用
CN115867542A (zh) 新型苯并咪唑化合物
JP7679090B2 (ja) 置換ヒドロキシスチルベン化合物および誘導体、合成ならびにそれらの使用
BR112019009801A2 (pt) 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-hidróxi-3-(5-mercapto-1h-1,2,4-triazol-1-il)propil)piridin-3-il)óxi)benzonitrila e processos de preparação
US20250011302A1 (en) Indole bipyrimidine compound, and intermediate thereof, preparation method therefor and use thereof
CN104974171B (zh) 二氢青蒿素苯基醚衍生物及其应用